Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the 'Company”), a clinical stage pharmaceutical company, today announced ...

BriaCell’s most-recent 25-patient cohort* have surpassed the one-year survival milestone, exceeding current standard of care ...

Research, Development and Innovation (RDI) scheme targets long-gestation, high-risk technologies via flexible capital routed ...

This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial Coll ...

Sachin Dear Sachin, Bachelor of Business Administration (BBA) will provide a solid foundation for understanding business ...

Designed to be flexible and future-focused, these programmes incorporate NEP’s multiple-entry and exit options, allowing ...

NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO’s ...

Israel’s technological rise is shaped by the strategic choices of global capital. In 2022, $22 billion in foreign direct ...

Trump’s tax bill could reshape drug R&D, manufacturing, Medicaid access, clinical trials, and biotech funding, impacting ...

Avalo Therapeutics, Inc. (NASDAQ:AVTX) is among the best growth stocks to invest in for the next 5 years. On Monday, the ...